Emergency Assistance Japan Valuation

Q: What is the Fair Price of 6063 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

6063 (¥661) is trading above our estimate of [[fair value]] (¥125.5)

Is 6063 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 6063 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 6063 (¥661) is trading above our estimate of fair value (¥125.5)

Significantly Below Fair Value: 6063 is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 6063?

Key metric: As 6063 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 6063. This is calculated by dividing 6063's market cap by their current earnings.
What is 6063's PE Ratio?
PE Ratio	69.4x
Earnings	JP¥24.00m
Market Cap	JP¥1.67b

6063 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	0.1x
Enterprise Value/EBITDA	4.4x
PEG Ratio	n/a

Price to Earnings Ratio vs Peers

How does 6063's PE Ratio compare to its peers?

The above table shows the PE ratio for 6063 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	16.2x
7090 Ligua	16.6x	n/a	JP¥1.6b
189A D & M Company	10.8x	n/a	JP¥1.9b
9214 Recovery InternationalLtd	20.6x	n/a	JP¥1.9b
2435 CEDAR.Co.Ltd	16.8x	n/a	JP¥2.6b
6063 Emergency Assistance Japan	69.4x	n/a	JP¥1.7b

Price-To-Earnings vs Peers: 6063 is expensive based on its Price-To-Earnings Ratio (69.4x) compared to the peer average (16x).

Price to Earnings Ratio vs Industry

How does 6063's PE Ratio compare vs other companies in the JP Healthcare Industry?

0 Companies	Price / Earnings	Estimated Growth	Market Cap

No more companies available in this PE range

0 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Earnings vs Industry: 6063 is expensive based on its Price-To-Earnings Ratio (69.4x) compared to the JP Healthcare industry average (14x).

Price to Earnings Ratio vs Fair Ratio

What is 6063's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

6063 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	69.4x
Fair PE Ratio	n/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 6063's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

FINDEX

JP¥20.5b

Offers medical systems, office systems, and Healthtech products in Japan.

3649

JP¥800.00

-0.7%

-12.5%

Charm Care

JP¥40.4b

Engages in nursing care business.

6062

JP¥1,238.00

2.1%

4.5%

Suzuken

JP¥383.2b

Primarily engages in the distribution of pharmaceuticals in Japan and internationally.

9987

JP¥4,936.00

-2.8%

-1.8%